Back to FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ FORT WASHINGTON INVESTMENT ADVISORS INC /OH/

ALXNALXN
7 quarters

Position history for FORT WASHINGTON INVESTMENT ADVISORS INC /OH/FORT WASHINGTON INVESTMENT ADVISORS INC /OH/'s holdings in ALEXION PHARMACEUTICALS INC

FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ previously held 0 shares of ALXN (ALEXION PHARMACEUTICALS INC), worth $0 as of 2021-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$229,000

Total Shares Change

-1,699

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q3
Latest
Exited
0
-100.0%
$00.0%
0
2021-Q2
New
1,098
-
$202,0000.0%
32
2020-Q1
Exited
0
-100.0%
$00.0%
0
2019-Q4
Unchanged
2,117
0.0%
$229,0000.0%
0
2019-Q3
Increased
2,117
+17.0%
$207,0000.0%
27
2019-Q2
Increased
1,810
+6.5%
$237,0000.0%
25
2019-Q1
New
1,699
-
$229,0000.0%
32

Other major holders of ALXN: FARALLON CAPITAL MANAGEMENT, L.L.C., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, HBK INVESTMENTS L P

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used